• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Exits

Gilde Healthcare's RAD-X joins busy radiology pipeline

  • Rachel Lewis, Patrick Costello, Claude Risner, Gustav Hoejmark-Jensen and Mintoi Chessa-Florea
  • 03 May 2022
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Gilde Healthcare has mandated Lincoln International to sell DACH radiology asset RAD-X, according to four sources familiar with the situation.

The sale is likely to attract the interest of consolidators backed by infrastructure funds including EQT’s Meine Radiologie and DWS Infrastructure’s Medipass, said a fifth source, as well as private equity-backed assets like Telemos Capital’s MedEuropa.

Infra funds have become interested in these assets because of the long cash flow predictability, said a sixth source, adding that as bidders, infra funds have a strong competitive advantage due to the lower returns required.

The sponsor formed RAD-X in 2016, growing it to 14 sites across Germany and Switzerland largely through a buy-and-build rollup. It has around EUR 15m-EUR 20m EBITDA, said one of the sources.

The company’s founder and CEO Martin Hardens will likely want to stay on board as he was one of the first to talk about consolidating the imaging sector and has driven much of the company’s growth, said a seventh source.

Lincoln International, Gilde Healthcare and RAD-X did not respond to a request for comment.

EQT already owns two German radiology platforms through its infrastructure arm, after it bought Meine Radiologie from Triton and Blikk from DBAG last year to merge the assets. It signed those deals at 15x-17x EBITDA multiples, according to an eight source.

The sponsor then bolted on a carve-out of Aleris’ radiology arm in the Nordics at 11x EBITDA, as reported by Unquote.

DWS Infrastructure has also recently moved its Italian radiology and radiotherapy asset Medipass into Germany, by acquiring RadioOnkologieNetzwerk. Both Medipass and MedEuropa have a strong radiotherapy segment, unlike RAD-X.

In Switzerland, Naxicap Partners acquired Groupe 3R, which the year prior had EBITDA of around EUR 9m, as reported.

At the large-mid cap side of the market, Belgian investor GBL recently acquired Affidea, a pan-European radiology company with upwards of EUR 100m EBITDA, and family office AP Moeller bought Unilabs with EUR 600m EBITDA. Both of those groups have operations in Switzerland but neither has in Germany.

In healthcare services, attention has very much moved away from ophthalmology towards other rollup plays that are more fragmented and have the same defensive traits, said a ninth source.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Exits
  • Healthcare
  • DACH
  • Lincoln International
  • Germany

More on Exits

Public sector software
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • Exits
  • 04 September 2023
Lender taking the keys from a sponsor
Ares Management handed keys to two-thirds of UK sponsor’s portfolio

Lender provided GBP 500m for three of the GP's deals between 2016 and 2019, Debtwire reported

  • Financing
  • 30 August 2023
Luggage and airport services
Actera Group explores strategic options for Celebi Ground Handling

Several investors placed bids for the company in 2022 but mismatch in pricing didn't lead to a deal

  • Exits
  • 30 August 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013